Detalhe da pesquisa
1.
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
J Surg Oncol
; 129(4): 734-744, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073160
2.
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial.
Gastric Cancer
; 25(2): 401-410, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714423
3.
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Gastric Cancer
; 25(3): 640-651, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129727
4.
Gastric and duodenal cancer in individuals with Lynch syndrome: a nationwide cohort study.
EClinicalMedicine
; 69: 102494, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404296
5.
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer.
Cancers (Basel)
; 14(12)2022 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740628
6.
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial.
Cancers (Basel)
; 13(18)2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572852